[eBook] Therapeutic proteins: bioprocessing methods for mAb generation
Supplied by Eppendorf on Wednesday, 20 November, 2024
Antibodies have long been vital in research and diagnostics, but their lab utility was limited by their polyclonal nature. To stay competitive, production must become more efficient, cost-effective, and higher in quality.
Download this eBook to learn about:
·key methods for mAb validation and development
·the potential of P. pastoris as a next-gen mAb production platform
·strategies for ensuring reliable, reproducible mAb research and drug development.
Related White Papers
How to raise antibody standards and improve reproducibility
Currently 70% of researchers fail to reproduce experiments. With so much research built on...
Digital innovation drives smarter, faster biologics development
[Case study] From bottleneck to breakthroughs: a...
How to streamline your research from molecule to medicine — case studies
Learn how organisations are leveraging the latest...
